MarketPulse

clinical trial success

2 articles
BenzingaBenzinga··Vandana Singh

AstraZeneca Powers Ahead in COPD with Blockbuster Trial Win, Eyes $3-5B Peak Sales

AstraZeneca's tozorakimab shows positive Phase 3 COPD data, reducing exacerbations versus placebo. Stock rises 3.68% premarket; company forecasts $3-5B peak sales.
SNYAZNREGNmonoclonal antibodyPhase 3 trials
BenzingaBenzinga··Vandana Singh

Pfizer's Dual Cancer Wins Boost Stock as Prostate, Breast Trials Succeed

Pfizer shares rise on Phase 3 prostate cancer trial win and Phase 2 breast cancer success, validating its oncology pipeline and signaling near-term regulatory catalysts.
PFEbreast cancerPhase 3 trial